Guided Therapeutics Stock Price, News & Analysis (OTCBB:GTHP)

$0.02 0.00 (-4.19 %)
(As of 01/23/2018 04:57 AM ET)
Previous Close$0.02
Today's Range$0.02 - $0.02
52-Week Range$0.01 - $2.12
Volume3.48 million shs
Average Volume2.52 million shs
Market Capitalization$56,536.00
P/E Ratio0.00
Dividend YieldN/A
Beta0.1

About Guided Therapeutics (OTCBB:GTHP)

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The Company's technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The Company focuses on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage. Its product, in addition to detecting the structural changes attributed to cervical cancer, is also detects the biochemical changes that precede the development of visual lesions. LuViva consists of three components: Touch screen monitor, Hand Held Unit (HHU) and the Wheeled Base.

Receive GTHP News and Ratings via Email

Sign-up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCBB:GTHP
CUSIPN/A
Phone+1-770-2428723

Debt

Debt-to-Equity RatioN/A
Current Ratio0.07%
Quick Ratio0.02%

Price-To-Earnings

Trailing P/E Ratio-0.0029038112522686
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$600,000.00
Price / Sales0.52
Cash FlowN/A
Price / CashN/A
Book Value($15.78) per share
Price / Book0.00

Profitability

Trailing EPS($5.51)
Net Income$-3,970,000.00
Net Margins-2,052.77%
Return on EquityN/A
Return on Assets-413.61%

Miscellaneous

Employees13
Outstanding Shares19,450,000

Guided Therapeutics (OTCBB:GTHP) Frequently Asked Questions

What is Guided Therapeutics' stock symbol?

Guided Therapeutics trades on the OTCBB under the ticker symbol "GTHP."

How were Guided Therapeutics' earnings last quarter?

Guided Therapeutics Inc (OTCBB:GTHP) issued its quarterly earnings data on Monday, November, 20th. The medical technology company reported ($0.35) earnings per share for the quarter. The medical technology company earned $0.03 million during the quarter. View Guided Therapeutics' Earnings History.

Who are Guided Therapeutics' key executives?

Guided Therapeutics' management team includes the folowing people:

  • Michael C. James, Independent Chairman and Director (Age 58)
  • Gene S. Cartwright Ph.D., Chief Executive Officer, Acting Chief Financial Officer, President and Director (Age 62)
  • Mark L. Faupel Ph.D., Chief Operating Officer, Director (Age 61)
  • Richard L. Fowler, Senior Vice President - Engineering (Age 59)
  • Richard P. Blumberg, Director
  • Jonathan M. Niloff M.D., Director (Age 62)
  • John E. Imhoff M.D., Independent Director (Age 67)
  • Linda M. Rosenstock M.D., Independent Director (Age 65)

How do I buy Guided Therapeutics stock?

Shares of Guided Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Guided Therapeutics' stock price today?

One share of Guided Therapeutics stock can currently be purchased for approximately $0.02.

How big of a company is Guided Therapeutics?

Guided Therapeutics has a market capitalization of $56,536.00 and generates $600,000.00 in revenue each year. The medical technology company earns $-3,970,000.00 in net income (profit) each year or ($5.51) on an earnings per share basis. Guided Therapeutics employs 13 workers across the globe.

How can I contact Guided Therapeutics?

Guided Therapeutics' mailing address is 5835 Peachtree Cors E Ste D, NORCROSS, GA 30092-3413, United States. The medical technology company can be reached via phone at +1-770-2428723 or via email at [email protected]


MarketBeat Community Rating for Guided Therapeutics (GTHP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Guided Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Guided Therapeutics (OTCBB:GTHP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Guided Therapeutics (OTCBB:GTHP) Earnings History and Estimates Chart

Earnings by Quarter for Guided Therapeutics (OTCBB:GTHP)

Guided Therapeutics (OTCBB GTHP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/20/2017Q3 2017($0.35)$0.03 millionViewN/AView Earnings Details
5/22/2017Q1 2017($0.22)$0.02 millionViewN/AView Earnings Details
3/27/2013Q4 12($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Guided Therapeutics (OTCBB:GTHP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Guided Therapeutics (OTCBB:GTHP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Guided Therapeutics (OTCBB GTHP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 85.82%
Insider Trades by Quarter for Guided Therapeutics (OTCBB:GTHP)

Guided Therapeutics (OTCBB GTHP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/8/2015Ronald W HartDirectorSell3,906$0.16$624.96View SEC Filing  
1/16/2015Ronald W HartDirectorSell2,717$0.23$624.91View SEC Filing  
7/2/2014Ronald W HartDirectorSell7,500$0.50$3,750.00View SEC Filing  
6/18/2014Gene S CartwrightCEOBuy76,000$0.48$36,480.00View SEC Filing  
6/17/2014Gene S CartwrightCEOBuy24,000$0.49$11,760.00View SEC Filing  
6/2/2014Ronald W HartDirectorSell12,500$0.50$6,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Guided Therapeutics (OTCBB GTHP) News Headlines

Source:
DateHeadline
Guided Therapeutics Signs Preliminary License Agreement with Turkish Distribution Partner Based on Ministry of Health Support for the LuViva Advanced Cervical ScanGuided Therapeutics Signs Preliminary License Agreement with Turkish Distribution Partner Based on Ministry of Health Support for the LuViva Advanced Cervical Scan
finance.yahoo.com - December 8 at 11:06 AM
Guided Therapeutics Continues to Grow International Sales with New Order of Disposables from Indonesia and Letter of Intent for Distribution in IndiaGuided Therapeutics Continues to Grow International Sales with New Order of Disposables from Indonesia and Letter of Intent for Distribution in India
finance.yahoo.com - November 28 at 4:01 PM
Guided Therapeutics Inc. (GTHP) Posts  Earnings ResultsGuided Therapeutics Inc. (GTHP) Posts Earnings Results
www.americanbankingnews.com - November 21 at 10:14 AM
Guided Therapeutics Re-establishes Communications with U.S. FDA and Discusses Plan for Refiling for Approval of the LuViva® Advanced Cervical ScanGuided Therapeutics Re-establishes Communications with U.S. FDA and Discusses Plan for Refiling for Approval of the LuViva® Advanced Cervical Scan
finance.yahoo.com - August 3 at 7:16 PM
Guided Therapeutics Re-establishes Communications with U.S. FDA and Discusses Plan for Refiling for Approval of the LuViva® Advanced Cervical ScanGuided Therapeutics Re-establishes Communications with U.S. FDA and Discusses Plan for Refiling for Approval of the LuViva® Advanced Cervical Scan
finance.yahoo.com - July 18 at 9:09 PM
GUIDED THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhiGUIDED THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi
biz.yahoo.com - March 30 at 5:58 PM
GUIDED THERAPEUTICS INC Files SEC form 10-K, Annual ReportGUIDED THERAPEUTICS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 22 at 5:45 PM
Guided Therapeutics Enters into LuViva® Advanced Cervical Scan Manufacturing and License Agreement for ChinaGuided Therapeutics Enters into LuViva® Advanced Cervical Scan Manufacturing and License Agreement for China
au.finance.yahoo.com - January 25 at 6:55 PM
Pre-Open Stock Movers 12/08: (VYGR) (TLRD) (LULU) Higher; (OHRP) (VRNT) (CMTL) Lower (more...)Pre-Open Stock Movers 12/08: (VYGR) (TLRD) (LULU) Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
www.streetinsider.com - December 8 at 6:10 PM
Splits Calendar: Guided Therapeutics splits before market open today (1:800 ratio)Splits Calendar: Guided Therapeutics splits before market open today (1:800 ratio)
biz.yahoo.com - November 9 at 9:29 AM
Guided Therapeutics Announces 1:800 Reverse Stock Split And Elimination Of "Toxic" Convertible Securities From Its Balance SheetGuided Therapeutics Announces 1:800 Reverse Stock Split And Elimination Of "Toxic" Convertible Securities From Its Balance Sheet
www.thestreet.com - November 6 at 5:42 PM
CORRECTING and REPLACING Guided Therapeutics Announces 1:800 Reverse Stock Split and Elimination of “Toxic” Convertible Securities from its Balance SheetCORRECTING and REPLACING Guided Therapeutics Announces 1:800 Reverse Stock Split and Elimination of “Toxic” Convertible Securities from its Balance Sheet
www.businesswire.com - November 6 at 5:42 PM
GUIDED THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial StateGUIDED THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State
biz.yahoo.com - November 4 at 10:16 PM
GUIDED THERAPEUTICS INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Creation of a Direct FinancGUIDED THERAPEUTICS INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Creation of a Direct Financ
biz.yahoo.com - September 9 at 5:06 PM
Guided Therapeutics Inc (GTHP.OB)Guided Therapeutics Inc (GTHP.OB)
www.reuters.com - September 4 at 9:41 AM
Guided Therapeutics, Inc. (GTHP) Announces Large LuViva OrderGuided Therapeutics, Inc. (GTHP) Announces Large LuViva Order
www.streetinsider.com - September 1 at 8:15 AM
GUIDED THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsGUIDED THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - November 13 at 3:37 PM
GUIDED THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersGUIDED THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - November 12 at 1:19 PM

SEC Filings

Guided Therapeutics (OTCBB:GTHP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Guided Therapeutics (OTCBB GTHP) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.